Chimera Investment Corporation
CIM · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $34 | $60 | $197 | -$114 |
| % Growth | -43.7% | -69.5% | 273.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $34 | $60 | $197 | -$114 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $18 | $20 | $24 |
| SG&A Expenses | $21 | $18 | $20 | $24 |
| Sales & Mktg Exp. | $14 | $0 | $0 | $0 |
| Other Operating Expenses | $13 | $42 | $177 | -$137 |
| Operating Expenses | $34 | $60 | $197 | -$114 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | -0% |
| Other Income/Exp. Net | -$0 | $36 | $169 | -$147 |
| Pre-Tax Income | -$0 | $36 | $169 | -$147 |
| Tax Expense | $0 | $0 | $2 | -$0 |
| Net Income | -$1 | $35 | $167 | -$147 |
| % Margin | -1.7% | 59% | 84.9% | 129.1% |
| EPS | -0.27 | 0.17 | 1.79 | -1.81 |
| % Growth | -258.8% | -90.5% | 198.9% | – |
| EPS Diluted | -0.27 | 0.17 | 1.77 | -1.78 |
| Weighted Avg Shares Out | 82 | 81 | 81 | 81 |
| Weighted Avg Shares Out Dil | 82 | 83 | 82 | 82 |
| Supplemental Information | – | – | – | – |
| Interest Income | $210 | $201 | $191 | $192 |
| Interest Expense | $144 | $135 | $121 | $127 |
| Depreciation & Amortization | $0 | $0 | $1 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | -0% |